You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Wednesday, March 20, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - TUESDAY, MAY 22ND, 2012
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 12558.4 53.92 (0.43%) | NASDAQ 2849.1 1.89 (0.07%) | S&P 500 1323.16 7.17 (0.54%)
|
Time of Screening :
5/22/2012 11:49:29 AM Report Released :
5/22/2012 12:25:09 PM
Price is:
Above 52W High and Less Than 52W High
but within 8% of the 52 Week High
Volume Is:
At least 57.5% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(50 DAV) |
52 Wk Hi
% From Hi |
Date
Featured |
Price
Featured |
Pivot Point |
|
Max Buy |
ALXN
- NASDAQ
Alexion Pharmaceuticals
|
$93.80
|
+5.04
5.68%
|
$94.36
|
2,760,091
214.58% of 50 DAV
50 DAV is 1,286,300
|
$95.01
-1.27%
|
5/1/2012 |
$91.73
|
PP = $95.11
MB = $99.87 |
Most Recent Note - 5/22/2012 11:56:08 AM
G - Today's impressive gap up gain above its 50 DMA line helped its technical stance and outlook improve. At the close of trading Thursday, Alexion will replace Motorola Mobility Holdings Inc in the S&P 500 Index. Recent lows define near-term chart support well above its 200 DMA line.
>>> The latest Featured Stock Update with an annotated graph appeared on 4/16/2012. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NTES
- NASDAQ
Netease Inc Adr
|
$59.41
|
+0.84
1.43%
|
$60.06
|
578,544
80.47% of 50 DAV
50 DAV is 719,000
|
$63.07
-5.80%
|
3/19/2012 |
$56.18
|
PP = $55.10
MB = $57.86 |
Most Recent Note - 5/22/2012 12:16:31 PM
G - Found support above its 50 DMA line after 2 losing sessions with above average volume since its big volume-driven gain on 5/17/12 for a new 52-week high. It had not formed a sound base pattern, however no overhead supply remains to act as resistance. Reported earnings +33% on +36% sales revenues for the quarter ended March 31, 2012 versus the year ago period and it received an analyst upgrade. Recent lows near the $55 area define important chart support to watch.
>>> The latest Featured Stock Update with an annotated graph appeared on 3/27/2012. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
ALGN
- NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Align Technology Inc
|
$31.85 |
+0.64
2.05%
|
$32.17
|
$34.29
|
-7.12% |
492,954
61.64%
|
799,700
|
Most Recent Note for ALGN - 5/22/2012 11:55:06 AM
Found support at its 50 DMA line during its consolidation since last noted when it gapped up on 4/24/12 for a considerable gain and new 52-week and all-time highs. Reported earnings +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period. The prior quarterly comparison (Dec '11) also showed strong sales and earnings increases following 4 previous quarters with earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08. The Medical - Supplies group has improved (Group RS rating is 90), which is encouraging news concerning the L criteria.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AZO
- NYSE - RETAIL - Auto Parts Stores
Autozone Inc
|
$369.83 |
+1.28
0.35%
|
$374.83
|
$399.10
|
-7.33% |
659,954
154.41%
|
427,400
|
Most Recent Note for AZO - 5/22/2012 11:59:05 AM
Slumped below its 50 DMA line and prior lows with a damaging volume-driven loss on 5/17/12. It made little headway after last noted when hitting a new 52-week high with a volume-driven gain in the 4/26/12 mid-day report - "Reported earnings +24% on +9% sales revenues for the quarter ended January 31, 2012 versus the year ago period. It has shown strong annual earnings (A criteria) growth while its quarterly increases have been borderline with the minimum +25% guideline for the C criteria. It is already heavily owned by mutual funds. While consumers are fixing their old cars and holding off on new car purchases, AZO and similar players in the auto-repair arena have shown some leadership."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CYBX
- NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Cyberonics Inc
|
$37.81 |
-1.33
-3.40%
|
$38.61
|
$40.29
|
-6.16% |
205,325
110.63%
|
185,600
|
Most Recent Note for CYBX - 5/22/2012 12:02:57 PM
Loss today on higher volume is violating its 50 DMA line and raising concerns while slumping toward important near-term support at prior lows in the $36 area. Reported earnings +36% on +16% sales revenues for the quarter ended January 31, 2012 versus the year ago period, marking 2 consecutive quarterly earnings comparisons above the +25% guideline. Prior mid-day reports noted - "Prior quarterly comparisons and annual earnings (C and A criteria) history is not a match with the fact-based investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DSW
- NYSE - RETAIL - Apparel Stores
D S W Inc
|
$60.79 |
+4.99
8.94%
|
$61.89
|
$61.89
|
-1.78% |
1,016,805
213.75%
|
475,700
|
Most Recent Note for DSW - 5/22/2012 12:05:39 PM
Gapped up today and hit a new 52-week high. No resistance remains due to overhead supply. Recently found support near its 50 DMA line while encountering distributional pressure near its all-time highs. Reported earnings +13% on +11% sales revenues for the quarter ended April 30, 2012 versus the year ago period. Last noted in the 4/03/12 mid-day report - "Reported earnings +24% on +10% sales revenues for the quarter ended January 31, 2012 versus the year ago period. Recent quarterly comparisons and earnings had improved greatly, but the Oct '11 period showed earnings +11% on +8% sales revenues, below the guidelines of the fact-based system, and a downturn in FY '08 & '09 annual earnings (A criteria) history is another fundamental flaw."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MBWM
- NASDAQ - BANKING - Regional - Midwest Banks
Mercantile Bank Corp
|
$14.62 |
-0.38
-2.53%
|
$14.98
|
$15.49
|
-5.62% |
24,402
76.74%
|
31,800
|
Most Recent Note for MBWM - 5/22/2012 12:14:29 PM
Today's 5th consecutive loss has it testing and trading below its 50 DMA line for the first time since October 2011. Sales revenues and earnings history is not a match with the fact-based investment system's guidelines today. It survived but failed to impress since noted in the 7/25/05 mid-day report - "Technically not desirable."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$144.86 |
-0.21
-0.14%
|
$145.24
|
$152.31
|
-4.89% |
1,587,015
470.51%
|
337,300
|
Most Recent Note for NVO - 5/22/2012 12:18:19 PM
Churning heavy volume today after a volume-driven gain on the prior session helped it rally near its 50 DMA line which may now act as a resistance level. Perched -5% off its all-time high. Its 3 latest quarterly comparisons through Mar '12 had earnings increases below the +25% guideline (not meeting the C criteria). It went through a deep consolidation below its 200 DMA line then rebounded since noted in the 7/28/11 mid-day report. - "It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. This Denmark-based Medical - Ethical Drug firm also has seen the number of top-rated funds owning its shares rise from 152 in Mar '10 to 204 in Mar '11, a reassuring sign concerning the I criteria."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NWSA
- NASDAQ - MEDIA - Entertainment - Diversified
News Corporation Cl A
|
$19.68 |
+0.18
0.90%
|
$19.69
|
$20.70
|
-4.95% |
8,977,903
59.28%
|
15,144,100
|
Most Recent Note for NWSA - 5/22/2012 12:19:14 PM
Halted its slide after a streak of 6 consecutive losses, and today it is trading near its 50 DMA line. Slumped back into its prior base after hitting a new 52-week high, encountering resistance following its gap up on 5/10/12 after reporting earnings +42% on +2% sales revenues for the quarter ended March 31, 2012 versus the year ago period. Quarterly and annual sales revenues and earnings history is not a match with the fact-based system's guidelines.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OABC
- NASDAQ - BANKING - Regional - Southwest Banks
Omniamerican Bancorp
|
$20.15 |
-0.09
-0.44%
|
$20.24
|
$20.71
|
-2.70% |
490,251
2,025.83%
|
24,200
|
Most Recent Note for OABC - 5/22/2012 12:22:22 PM
Rebounded from earlier lows today after briefly trading below its 50 DMA line for the first time since November 2011. Perched -2.5% off its 52-week high with no resistance remaining due to overhead supply. Last noted in the 4/20/12 mid-day report - "Recent quarters showed better earnings versus the year earlier, however unimpressive sales revenues growth suggests no great demand for new (N criteria) products or services."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PETM
- NASDAQ - SPECIALTY RETAIL - Specialty Retail, Other
Petsmart Inc
|
$56.12 |
+0.39
0.69%
|
$56.25
|
$59.36
|
-5.47% |
605,188
67.91%
|
891,100
|
Most Recent Note for PETM - 5/22/2012 12:24:46 PM
Still perched within -5.7% of its 52-week high today, yet trading below its 50 DMA line after damaging distributional losses on heavy volume within the past week. Reported earnings +18% on +8% sales revenues for the quarter ended January 31, 2012 versus the year ago period. Noted in prior mid-day reports - "Quarterly sales revenues increases in the +6-8% are below the robust growth guidelines of the investment system. Its earnings and sales revenues showed improvement in the recent quarterly comparisons but its growth history is below the fundamental guidelines of the investment system. Current earnings per share should be up +25% or more and the past 3 or 4 comparisons in many cases accelerating in recent quarters. Quarterly sales should also be up +18-25% or more or accelerating over prior quarters."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
|
